Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Aspen Aerogels Inc’s stock clocked out at $3.22, down -4.45% from its previous closing price of $3.37. In other words, the price has decreased by -$4.45 from its previous closing price. On the day, 1.05 million shares were traded. ASPN stock price reached its highest trading level at $3.41 during the session, while it also had its lowest trading level at $3.2.
Ratios:
To gain a deeper understanding of ASPN’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 98.93. For the most recent quarter (mrq), Quick Ratio is recorded 3.33 and its Current Ratio is at 3.94. In the meantime, Its Debt-to-Equity ratio is 0.49 whereas as Long-Term Debt/Eq ratio is at 0.38.
On May 29, 2025, Barclays Downgraded its rating to Equal Weight which previously was Overweight but kept the price unchanged to $7.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 13 ’25 when Young Donald R sold 56,845 shares for $3.23 per share. The transaction valued at 183,609 led to the insider holds 494,011 shares of the business.
DONALD YOUNG bought 56,845 shares of ASPN for $194,978 on Nov 13 ’25. On Aug 12 ’25, another insider, Daniel Santhosh P, who serves as the Chief Accounting Officer of the company, sold 4,410 shares for $7.31 each. As a result, the insider received 32,237 and left with 19,879 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASPN now has a Market Capitalization of 266123600 and an Enterprise Value of 265556608. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.75 while its Price-to-Book (P/B) ratio in mrq is 0.87. Its current Enterprise Value per Revenue stands at 0.753 whereas that against EBITDA is 7.822.
Stock Price History:
The Beta on a monthly basis for ASPN is 2.93, which has changed by -0.7393658 over the last 52 weeks, in comparison to a change of 0.13613915 over the same period for the S&P500. Over the past 52 weeks, ASPN has reached a high of $14.30, while it has fallen to a 52-week low of $2.92. The 50-Day Moving Average of the stock is -42.50%, while the 200-Day Moving Average is calculated to be -48.96%.
Shares Statistics:
It appears that ASPN traded 2.35M shares on average per day over the past three months and 1827640 shares per day over the past ten days. A total of 82.56M shares are outstanding, with a floating share count of 69.05M. Insiders hold about 16.51% of the company’s shares, while institutions hold 72.03% stake in the company. Shares short for ASPN as of 1764288000 were 8561660 with a Short Ratio of 3.65, compared to 1761868800 on 8544699. Therefore, it implies a Short% of Shares Outstanding of 8561660 and a Short% of Float of 12.370000000000001.
Earnings Estimates
. The current rating of Aspen Aerogels Inc (ASPN) reflects the combined expertise of 5.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.15, with high estimates of -$0.06 and low estimates of -$0.18.
Analysts are recommending an EPS of between -$0.32 and -$3.99 for the fiscal current year, implying an average EPS of -$1.3. EPS for the following year is -$0.32, with 5.0 analysts recommending between -$0.18 and -$0.47.
Revenue Estimates
In. The current quarter, 7 analysts expect revenue to total $44.42M. It ranges from a high estimate of $48.3M to a low estimate of $40.5M. As of. The current estimate, Aspen Aerogels Inc’s year-ago sales were $123.09MFor the next quarter, 7 analysts are estimating revenue of $49.1M. There is a high estimate of $56.7M for the next quarter, whereas the lowest estimate is $44M.
A total of 7 analysts have provided revenue estimates for ASPN’s current fiscal year. The highest revenue estimate was $278.1M, while the lowest revenue estimate was $270.3M, resulting in an average revenue estimate of $274.21M. In the same quarter a year ago, actual revenue was $452.7MBased on 7 analysts’ estimates, the company’s revenue will be $236.43M in the next fiscal year. The high estimate is $259.65M and the low estimate is $205.4M.
